Natalie Sacks

Clinical Trial Tests Drug Combination in Mesothelioma

UPDATE: Aduro Biotech announced on December 12 that they have decided to discontinue its CRS-207 clinical trial and wind down each of its trials in mesothelioma. This decision was made based on preliminary results from the trials, as well as a business and commercial assessment.
On November 8, 2017, the Meso Foundation hosted a Meet the Mesothelioma […]